[ad_1]
An artificial intelligence system recorded a 2-0 victory against elite doctors in two rounds of a competition in Beijing to diagnose brain tumors and predict the expansion of cerebral hematomas, or bruises.
BioMind, developed by researchers at the AI Research Center for Neurological Disorders and Capital Medical University, makes correct diagnoses in 87% of the 225 cases in about 15 minutes.
A team of 15 doctors from the best hospitals in China achieves 66% accuracy in 30 minutes. The AI system also made correct predictions in 83% of cases of cerebral hematoma expansion, surpassing the doctors, who had only 63% accuracy.
"I am not at all surprised by the results," said Wang Yongjun chairman of Beijing Tiantan Hospital, which houses the research center
To train the AI, the developers have nurtured tens of thousands of images of nervous system-related diseases that the Tiantan hospital has archived over the past 10 years. he said, Cheng Jingliang, professor of radiology at First Affiliated Hospital of Zhengzhou University in Zhengzhou, Henan Province, said that the AI had already done research on common neurological diseases . have been used to help doctors read images, such as pulmonary scans, for diagnoses in some Chinese hospitals
However, the use of AI is still in its infancy in the medical field and the accuracy of diagnoses In most cases, he stated that this was the case for top professionals. Paul Parizel, chairman of the radiology department of the Antwerp University Hospital in Belgium and a jury member of the competition, said that the integration of AI in medical services is a trend promising.
"It will be like a GPS guiding a He will make proposals to a doctor and help the doctor diagnose," he said. "But it will ultimately be the doctor who will decide, because there are a number of factors that a machine can not take into consideration, such as the patient's state of health and his family situation."
AI has been increasingly used in medical care in China in recent years.
In June, the Swedish medical company Elekta announced the introduction of Watson for Oncology, a medical AI system developed by IBM in the United States. for cancer patients in China. The AI platform has been used in 68 hospitals across China to assist in the treatment of cancer. – China Daily / ANN
[ad_2]
Source link
